LEGN Legend Biotech Corp
P/E
--
Forward P/E
25.38
Price/Sales
2.948
Beta
0.573
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Legend Biotech reports third quarter 2026 revenue of $360M and $0.13 EPS beating estimates
Legend Biotech achieved profitability in the third quarter of 2026, driven by a sharp increase in commercial revenue and disciplined expense management. Total...
Legend Biotech Corp Q3 2026 Earnings Preview: What Analysts Expect on November 10, 2026
Wall Street expects Legend Biotech to report Q3 2026 revenue of $302.5 million and EPS of $0.01, with the current $52.45 share price trading significantly...